Results 201 to 207 of about 10,402 (207)

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer

Gynecologic Oncology, 2006
G De Masi, E Ferrazzi
exaly  

Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience

Cancer Investigation, 2002
Charles L Vogel
exaly  

Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up

Gynecologic Oncology, 2006
Hung-Hsueh Chou, Kung-Liahng Wang, Chi-An Chen   +2 more
exaly  

Pegylated liposomal doxorubicin is less cardiotoxic than conventional doxorubicin,

Reactions Weekly, 1998
openaire   +1 more source

Pegylated liposomal Doxorubicine in classic Kaposi's Sarcoma: a viewpoint

2006
MONTESU, Maria Antonia, Masala MV, SATTA, Rosanna Rita, Cottoni F.   +3 more
openaire   +2 more sources

Pegylated liposomal doxorubicin for relapsed ovarian cancer

2008
Alison Cameron, Emma Gray, Chris Williams   +2 more
openaire   +1 more source

Pegylated liposomal doxorubicin promising in ovarian cancer

Inpharma Weekly, 2001
openaire   +1 more source